Literature DB >> 18443612

Ocular blood flow in diabetes and age-related macular degeneration.

Berthold Pemp1, Leopold Schmetterer.   

Abstract

The 2 leading causes of blindness in adults in the industrialized nations, diabetic retinopathy and age-related macular degeneration, have been investigated thoroughly with respect to their pathogenesis. In recent years, it has been discovered that dysfunctional ocular microcirculation appears to play a part in the development of both diseases. In diabetic retinopathy, it has been shown that the disease is associated with early retinal vascular dysregulation. In the later states of the disease, retinal tissue hypoxia is a major trigger of sight-threatening neovascularization. In age-related macular degeneration, there is increasing evidence that reduced blood flow in the choroid is associated with the development and progression of the disease. Knowledge of the pathophysiological vascular states underlying these diseases is essential for the assessment and development of future therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18443612     DOI: 10.3129/i08-049

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  73 in total

1.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

Review 2.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

3.  Total average blood flow and angiography in the rat retina.

Authors:  Vivek J Srinivasan; Harsha Radhakrishnan
Journal:  J Biomed Opt       Date:  2013-07       Impact factor: 3.170

4.  The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.

Authors:  Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-07       Impact factor: 3.117

5.  Lamina-specific functional MRI of retinal and choroidal responses to visual stimuli.

Authors:  Yen-Yu I Shih; Bryan H De la Garza; Eric R Muir; William E Rogers; Joseph M Harrison; Jeffrey W Kiel; Timothy Q Duong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-15       Impact factor: 4.799

6.  Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study.

Authors:  Jian Yu; Chunhui Jiang; Xiaolei Wang; Li Zhu; Ruiping Gu; Huan Xu; Yali Jia; David Huang; Xinghuai Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

7.  Blood flow velocity vector field reconstruction from dual-beam bidirectional Doppler OCT measurements in retinal veins.

Authors:  Gerold C Aschinger; Leopold Schmetterer; Veronika Doblhoff-Dier; Rainer A Leitgeb; Gerhard Garhöfer; Martin Gröschl; René M Werkmeister
Journal:  Biomed Opt Express       Date:  2015-04-06       Impact factor: 3.732

8.  Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles.

Authors:  T Dalsgaard; C Kroigaard; M Misfeldt; T Bek; U Simonsen
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

9.  Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab.

Authors:  Gökhan Pekel; Semra Acer; Ebru Nevin Çetin; Ramazan Yağcı; Alper Kaşıkçı; Ali Çevik
Journal:  Int Ophthalmol       Date:  2014-09-04       Impact factor: 2.031

10.  Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats.

Authors:  Justin Wanek; Pang-Yu Teng; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.